Cancer Cause and Prevention Research in Colorado
Cancer Cause and Prevention Research (93.393) awarded $46.2 million to recipients in Colorado in 39 grants from fiscal 2021 to 2025, 1.3% of the program's national total. The Regents of the University of Colorado received the most, $34.5 million.
- Awarded in Colorado$46.2 million
- Awards39
- Share of the program1.3%
- Rank among states24th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 21 | $8.8 million |
| FY 2022 | 22 | $10.1 million |
| FY 2023 | 20 | $9.0 million |
| FY 2024 | 17 | $8.0 million |
| FY 2025 | 16 | $10.3 million |
Recipients in Colorado
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of Colorado | Colleges and universities | 28 | $34.5 million |
| Klein Buendel, Inc. | Small businesses | 2 | $7.1 million |
| The Regents of the University of Colorado | Colleges and universities | 4 | $4.1 million |
| Calibermri, Inc. | Small businesses | 1 | $472,890 |
| Keystone Symposia on Molecular and Cellular Biology | Nonprofits | 4 | $42,000 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Colorado?
$46.2 million from fiscal 2021 to 2025, across 39 awards. Colorado ranks 24th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Colorado?
The largest recipient is The Regents of the University of Colorado, with $34.5 million in 28 awards. Next are Klein Buendel, Inc. and The Regents of the University of Colorado.
Can organizations in Colorado apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Colorado
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- 1332 State Innovation Waivers
- Special Education Grants to States
- Federal Transit Formula Grants